Role of the CXCR6/CXCL16 axis in autoimmune diseases
Nandi Bao,Bo Fu,Xiaoling Zhong,Shuangshuang Jia,Zhuangzhuang Ren,Haoran Wang,Weihua Wang,Hui Shi,Jun Li,Fulin Ge,Qing Chang,Yuan Gong,Wenhui Liu,Feng Qiu,Shiping Xu,Tingting Li
DOI: https://doi.org/10.1016/j.intimp.2023.110530
IF: 5.714
2023-06-21
International Immunopharmacology
Abstract:The C–X–C motif ligand 16, or CXCL16, is a chemokine that belongs to the ELR − CXC subfamily. Its function is to bind to the chemokine receptor CXCR6, which is a G protein-coupled receptor with 7 transmembrane domains. The CXCR6/CXCL16 axis has been linked to the development of numerous autoimmune diseases and is connected to clinical parameters that reflect disease severity, activity, and prognosis in conditions such as multiple sclerosis, autoimmune hepatitis, rheumatoid arthritis, Crohn's disease, and psoriasis. CXCL16 is expressed in various immune cells, such as dendritic cells, monocytes, macrophages, and B cells. During autoimmune diseases, CXCL16 can facilitate the adhesion of immune cells like monocytes, T cells, NKT cells, and others to endothelial cells and dendritic cells. Additionally, sCXCL16 can regulate the migration of CXCR6-expressing leukocytes, which includes CD8 + T cells, CD4 + T cells, NK cells, constant natural killer T cells, plasma cells, and monocytes. Further investigation is required to comprehend the intricate interactions between chemokines and the pathogenesis of autoimmune diseases. It remains to be seen whether the CXCR6/CXCL16 axis represents a new target for the treatment of these conditions.
pharmacology & pharmacy,immunology